Cleveland Clinic | Evaluate

August 29, 2017

ESC 2017 – Alivecor traces a path to increased sales

Orexigen’s heavy price for Light miscalculation

April 07, 2015

UniQure deal confirms red-hot interest in advanced therapies

June 28, 2013

Resverlogix doomed by second failure

June 07, 2013

Positive Avandia vote offers Glaxo little solace

November 16, 2011

AHA 2011 - CETP sweet spot in focus as third contender heads for phase III

November 15, 2011

AHA 2011 - Saturn confirms more statin is better whatever the brand

September 08, 2011

Vantage Point - Functionality in focus as HDL hypothesis awaits confirmation

June 30, 2011

Roche reaches end of Avastin appeal road

June 07, 2011

Vantage Point - Swelling TKI field prompts calls for new approaches in kidney cancer

November 18, 2010

AHA 2010 – Resverlogix falls back to earth

Load More